on-demand webinar
About this Webinar
CBN (Cannabinol) is an emerging non-intoxicating cannabinoid that research shows is a promising neuroprotectant, anti-inflammatory, stimulates appetite, and can reduce eye pressure in glaucoma patients. Combined with THC, CBN can increase euphoria, cause sedation, and help promote sleep and relaxation.

Learn about this cannabinoid, nanotechnology, and other tips to get a restful and rejuvenating sleep. Our guest speaker is Cameron Clarke, the Co-Founder, and CEO of the California cannabis manufacturer Sunderstorm, the parent company of Kanha gummies and NANO sublinguals.
Presenters
  • 1611782840-a687563e9237e970
    Farmacy Cannabis Lecture Series
  • 1614098737-c5129f0422c7a278
    Cameron Clarke
    Cameron Clarke is the Co-Founder and CEO of the California cannabis manufacturer Sunderstorm, the parent company of Kanha gummies, Wind Vapes, and NANO5 sublingual.

    He is a serial entrepreneur with a track record of transforming technical innovation into high-impact applications. In 1994 he co-founded Visionary Information Systems Inc. launching the modern electronic courtroom. In 2000 he founded Vodium, an internet-based video streaming company. His other ventures include Aero Glass, a pioneering company delivering augmented reality technology to pilots, and Amazon-Mania USA, an original importer of Acai berry products
    from Brazil.

    Cameron is also founder of several social projects including the Blue Nomad Foundation, a non-profit funding algae-based research for bioremediation and biopolymer development, and the Wet Lab in San Diego and Berkeley Biolabs biohacker spaces teaching synthetic biology and providing research facilities.

    Cameron is a graduate of Stanford University.
Share